The Charité in part belongs to the Humboldt-Universität which was founded in 1810 according to the concept by Wilhelm von Humboldt to make the University «mother of all modern universities». There have been 29 Nobel Price Winners who worked at the Humboldt-Universität, which has contributed to the international acclaim of its research.
With more than 430 professors and 38.000 students, it covers all the major academic disciplines in the Arts and Humanities, Social Science, Cultural Science, Agricultural Science, Mathematics, Economics and Law, Natural Sciences and, with the Charité, also Human Medicine.
The Charité University Medicine Berlin is one of the largest university hospitals in Europe. All of the clinical care, research and teaching is delivered by physicians and researchers of the highest international standard. Charité is internationally renowned for its excellence in teaching and training. Charité extends over four campuses, and has close to 100 different Departments and Institutes, which make up a total of 17 different Charité Centers. Having marked its 300-year anniversary in 2010, Charité is now one of the largest employers in Berlin, employing 13.760 staff (or 17.500 if including its subsidiaries), and with a total annual turnover of €1.6 billion.
Innovative capacity and responsible governance, for the benefit of patients and society – these are the central tenets behind all of Charité research endeavors. At Charité, approximately 3.700 researchers are actively engaged in the development of pioneering innovations in the field of medicine. Committed to the highest standards of quality and sustainability, they work across 1.000 projects, working groups and collaborative projects. There is a particular focus on the interface between basic and patient-oriented research, which seeks to foster interdisciplinary collaborations with both national and international partners. Harnessing the potential of this approach is of particular importance to Charité given that the most significant scientific developments are likely to arise from interdisciplinary cooperation.
In addition to its role in research and teaching, the Hospital’s fundamental mission also includes the care and treatment of patients. With 660.000 outpatient cases and approximately 140.000 inpatient cases a year, Charité treats more patients than any other university hospital in Germany and, as a result, is able to draw on a wealth of experience and expertise.
The Charité Oncology and Hematology medical centre specializes in the treatment of leukemia, lymphoma and solid tumors. For cancer diagnostics, the centre has the most modern, university-medical methods available. The treatment always takes place in close cooperation of all departments necessary to ensure best interdisciplinary care.
The goal is to ensure an individual therapy for every patient. In particular, the latest methods of immunotherapy are used here.
The Department of Hematology, Oncology and Tumorimmunology at the Charité University Medicine Berlin is concentrating on translational research focusing on the integrative analyses of “omics” and NGS data with the aim to further refine molecular tumor classification and to implement insights into innovative precision medicine approaches.
In addition, within the Charité Leukemia Program Prof. Lars Bullinger’s Group is also aiming to further advance innovative diagnostic concepts for hematological malignancies such as acute myeloid leukemia (AML) and he is coordinating the Molecular Oncology Diagnostics Lab for Labor Berlin, a spin-off company of the Charité.
CHARITÉ UNIVERSITY MEDICINE BERLIN
DEP. OF HEMATOLOGY, ONCOLOGY AND TUMORIMMUNOLOGY
PROF. BULLINGER’S GROUP, ONCO HEMATOLOGY RESEARCH